Apelin, Nitric Oxide and Vascular Affection in Adolescent Type 1 Diabetic Patients
DOI:
https://doi.org/10.3889/oamjms.2017.204Keywords:
Apelin, nitric oxide, FMD, adolescent, type 1 diabetesAbstract
AIM: To evaluate the relationship of apelin and nitric oxide (NO) to endothelial dysfunction in type 1 diabetics.
PATIENTS AND METHODS: Sixty two type 1 diabetics and 30 healthy age and sex matched controls were included. Blood samples for apelin, NO, glycosylated hemoglobin (HbA1c), and lipid profile were collected. Albumin/creatinine ratio was assessed in urine. Flow mediated dilatation (FMD) via ultrasound was done.
RESULTS: The mean age of diabetics were 16.3 ± 1.5 yrs (14.0 – 19.0 yrs), and duration of disease, were 9.4 ± 2.9 yrs (5.0 – 16.5 yrs). FMD and FMD/nitrate mediated dilatation (NMD) ratio were lower in diabetics. NO was decreased, while apelin and albumin/creatinine ratio were increased significantly in diabetics. There was a positive correlation between apelin and HbA1c. On the contrary, NO had a negative correlation with HbA1c, albumin/creatinine ratio, LDL-c and OxLDL.
CONCLUSION: Diabetic patients had endothelial dysfunction and high apelin level, with no related to each other. High level of apelin is associated with bad glycemic control. Obesity had no role to increase in apelin level. NO is related to diabetic nephropathy and atherosclerosis. We recommend a further large study to evaluate the relationship of apelin with endothelial dysfunction.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251:471-476. https://doi.org/10.1006/bbrc.1998.9489 PMid:9792798
Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptideapelin to human vascular and endocardial endothelial cells. Regul Pept 2004;118:119-125. https://doi.org/10.1016/j.regpep.2003.11.002 PMid:15003827
Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR, O'Dowd BF. Characterization of apelin, the ligand for the APJ receptor. J Neurochem. 2000;74:34-41. https://doi.org/10.1046/j.1471-4159.2000.0740034.x PMid:10617103
Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C, Audigier Y, Saulnier-Blache JS, Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146:1764-1771. https://doi.org/10.1210/en.2004-1427 PMid:15677759
Tasci I, Erdem G, Ozgur G, Tapan S, Dogru T, Genc H, Acikel C, Ozgurtas T, Sonmez A. LD cholesterol lowering increases plasma apelin in isolated hypercholesterolemia. Atherosclerosis. 2009;204:222-228. https://doi.org/10.1016/j.atherosclerosis.2008.08.030 PMid:18845302
Erdem G, Dogru T, Tasci I, Sonmez A, Tapan S. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2008;116:289-292. https://doi.org/10.1055/s-2007-1004564 PMid:18484561
DeFronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependentdiabetes. Diabetes. 1982;31:795-801. https://doi.org/10.2337/diab.31.9.795 PMid:6761214
Pang TT, Narendran P. Addressing insulin resistance in Type 1 diabetes. Diabet Med. 2008;25:1015-1024. https://doi.org/10.1111/j.1464-5491.2008.02493.x PMid:19183305
Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA. Obesity and insulin resistance in humans: a dose-response study. Metabolism. 1990;39:452-459. https://doi.org/10.1016/0026-0495(90)90002-T
Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia. 1996;39:1489-1497. https://doi.org/10.1007/s001250050603 PMid:8960831
Sinaiko AR, Jacobs DR, Jr., Steinberger J, Moran A, Luepker R, Rocchini AP, Prineas RJ. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr. 2001;139:700-707. https://doi.org/10.1067/mpd.2001.118535 PMid:11713450
Waldhor T, Schober E, Rami B. Regional distribution of risk for childhood diabetes in Austria and possible association with body mass index. Eur J Pediatr. 2003;162:380-384. PMid:12756559
Kibirige M, Metcalf B, Renuka R, Wilkin TJ. Testingthe accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care. 2003;26:2865-2870. https://doi.org/10.2337/diacare.26.10.2865 PMid:14514593
Baum JD, Ounsted M, Smith MA. Letter: Weight gain in infancy and subsequent development ofdiabetes mellitus in childhood. Lancet. 1975;2:866. https://doi.org/10.1016/S0140-6736(75)90250-0
Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia. 2001;44:914-922. https://doi.org/10.1007/s001250100548 PMid:11508279
Meral C, Tascilar C, Karademir F, Tanju IA, Cekmez F, Ipcioglu OM, Ercin CN, Gocmen I and Dogru T. Elevated Plasma Levels of Apelin in Children with Type 1 Diabetes Mellitus. Journal of Pediatric Endocrinology & Metabolism. 2010, 23, 497-502. https://doi.org/10.1515/jpem.2010.081 PMid:20662349
Soha M. Abd El Dayem, Ahmed A. Battah, Amal El-shehaby and Abo El Maged El Bohy. Asymmetric dimethyl L-arginine, nitric oxide and cardiovascular disease in adolescent type 1 diabetics. J Pediatr Endocr Met. 2014; 27(5-6): 437–444.
Sibal L, Agarwal SC, Schwedhelm E, Lüneburg N, Böger RH, et al. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria. Cardiovasc Diabetol. 2009;8:27. https://doi.org/10.1186/1475-2840-8-27 PMid:19486510 PMCid:PMC2698883
Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 1993; 87: V-67–V-76.
Järvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimäki T, Rönnemaa T, Viikari J, Raitakari OT. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004;109(14):1750-5. https://doi.org/10.1161/01.CIR.0000124725.46165.2C PMid:15023875
Tanner JM, Hiernaux J, Jarman S. Growth and physical studies. In: Weiner JS, Lourie JA, editors. Human biology: a guide to field methods. Oxford: Blackwell Scientific Publ. 1969:3–41.
Cameron N. The methods of auxological anthropology. In: Falkner F, Tanner JM, editors. Human growth 3 Methodology. New York: Plenum Press, 1986:3–46. PMid:3956717
Flegg HM. An investigation for the determination of serum cholesterol by an enzymatic method. Ann Clin Biochem. 1973;10:79–84. https://doi.org/10.1177/000456327301000125
Marques-Vidal P, Ferrario M, Kuulasmaa K, Grafnetter D, Moltchanov V, for the WHO MONICA Project. Quality assessment of data on HDL cholesterol in the WHO MONICA Project (1999). Available at: URL: http://www.thl.fi/publications/monica/hdl/hdlqa.htmURN:NBN:fi-fe19991137.
Danilova LA, Lopatina NI. Colorimetric method of determining glycosylated haemoglobin. Lab Delo. 1986;5:282–3.
Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Eng J Med. 1984;310:356–60. https://doi.org/10.1056/NEJM198402093100605 PMid:6690964
Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am CollCardiol. 2003; 41: 661–665. https://doi.org/10.1016/S0735-1097(02)02894-2
Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Schiffrin EL, Taddei S, Webb DJ. Endothelial function and dysfunction: part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005; 23: 7–17. https://doi.org/10.1097/00004872-200501000-00004 PMid:15643116
Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force [published correction appears in J Am Coll Cardiol. 2002;39:1082]. J Am Coll Cardiol. 2002; 39: 257–265. https://doi.org/10.1016/S0735-1097(01)01746-6
Kuvin JT, Patel AR, Sliney KA, Pandian NG, Rand WM, et al. Peripheral vascular endothelial function testing as a non invasive indicator of coronary artery disease. J Am Coll Cardiol. 2001;38:1843–1849. https://doi.org/10.1016/S0735-1097(01)01657-6
Palmieri V, Migliaresi P, Orefice M, Lupo T, Di Minno MN, et al. High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index. Nutr Metab Cardiovasc Dis. 2009;19:234–240. https://doi.org/10.1016/j.numecd.2008.09.009 PMid:19157818
Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med. 2004;42:1377–83. https://doi.org/10.1515/CCLM.2004.257 PMid:15576299
Altinova AE, Arslan M, Sepici-Dincel A, Akturk M, Altan N, et al. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations. J Clin Endocrinol Metabol. 2007;92:1881–5. https://doi.org/10.1210/jc.2006-2643 PMid:17311854
Wiltshire EJ, Gent R, Hirte C, et al. Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes. 2002; 51: 2282–2286. https://doi.org/10.2337/diabetes.51.7.2282 PMid:12086961
Donaghue KC, Robinson J, McCredie R, et al. Large vessel dysfunction in diabetic adolescents and its relationship to small vessel complications. J Pediatr Endocrinol Metab. 1997; 10: 593–598. https://doi.org/10.1515/JPEM.1997.10.6.593 PMid:9467129
Soha M Abd El Dayem, Abo El Maged El Bohy, Mohamed Ali, and Enass Moktar. Assessment of Endothelial Dysfunction, Coronary and Carotid Atherosclerosis In Type I Diabetics. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2017;8 (3):68-79.
Masri B, Knibiehler B, Audigier Y. Apelin signalling: a promising pathway from cloning to pharmacology. Cellular Signalling. 2005;17:415–426. https://doi.org/10.1016/j.cellsig.2004.09.018 PMid:15601620
Habchi M, Duvillard L, Cottet V, Brindisi MC, Bouillet B, Beacco M, Crevisy E, Buffier P, Baillot-Rudoni S, Verges B, Petit JM. Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control. Clin Endocrinol (Oxf). 2014;81(5):696-701. https://doi.org/10.1111/cen.12404 PMid:24417455
Valle A, Hoggard N, Adams AC, et al. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. Journal of Neuroendocrinology. 2008; 20: 79–84. PMid:18081555
Clarke KJ, Whitaker KW, Reyes TM. Diminished Metabolic Responses to Centrallyâ€Administered Apelinâ€13 in Dietâ€Induced Obese Rats Fed a Highâ€Fat Diet. Journal of neuroendocrinology. 2009;21(2):83-9. https://doi.org/10.1111/j.1365-2826.2008.01815.x PMid:19076266
Dray C, Knauf C, Daviaud D, et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metabolism. 2008; 8: 437–445. https://doi.org/10.1016/j.cmet.2008.10.003 PMid:19046574
Yue P, Jin H, Aillaud M, et al. Apelin is necessary for the maintenance of insulin sensitivity. American Journal of Physiology-Endocrinology and metabolism. 2010; 298: E59–E67. https://doi.org/10.1152/ajpendo.00385.2009 PMid:19861585 PMCid:PMC2806109
Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005; 146: 1764–1771. https://doi.org/10.1210/en.2004-1427 PMid:15677759
Li L, Yang G, Li Q, et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Experimental and Clinical Endocrinology & Diabetes. 2006; 114: 544–548. https://doi.org/10.1055/s-2006-948309 PMid:17177135
Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, et al. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obesity Surgery. 2009; 19: 1574–1580. https://doi.org/10.1007/s11695-009-9955-y PMid:19756893
Dray C, Debard C, Jager J, et al. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. American Journal of Physiology-Endocrinology and metabolism. 2010; 298: E1161–E1169. https://doi.org/10.1152/ajpendo.00598.2009 PMid:20233941
Erdem G, Dogru T, Tasci I, et al. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes. 2008;116:289–292. https://doi.org/10.1055/s-2007-1004564 PMid:18484561
Zhang Y, Shen C, Li X, et al. Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes Care. 2009; 32: e150. https://doi.org/10.2337/dc09-1146 PMid:19940213
Meral C, Tascilar E, Karademir F, et al. Elevated plasma levels of apelin in children with type 1 diabetes mellitus. Journal of Pediatric Endocrinology & Metabolism. 2010; 23: 497–502. https://doi.org/10.1515/jpem.2010.081
Alexiadou K, Kokkinos A, Liatis S, et al. Differences in plasma apelin and visfatin levels between patients with type 1 diabetes mellitus and healthy subjects and response after acute hyperglycemia and insulin administration. Hormones (Athens, Greece). 2012; 11: 444–450. https://doi.org/10.14310/horm.2002.1376
Cavallo MG, Sentinelli F, Barchetta I, et al. Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus. PLoS ONE. 2012; 7: e51236. https://doi.org/10.1371/journal.pone.0051236 PMid:23227256 PMCid:PMC3515542
Reinehr T, Woelfle J, Roth CL. Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis. Metabolism. 2011; 60:1349–1354. https://doi.org/10.1016/j.metabol.2011.02.005 PMid:21489579
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Soha M. El Dayem, Ahmed A. Battah, Abo El Maged El Bohy, Rash Nazih Yousef, Azza M. Ahmed, Ahmed A. Talaat (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0